Chengdu Kanghong Pharmaceutical Group Co., Ltd
Research Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) on Bullrun: market cap CNY 17.91B, P/E 18.3, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker002773.SZ
- ExchangeSZ
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCNY
- Market capCNY 17.91B
- P/E18.3
- Dividend yield3.6%
- Financial periodQ2 2026
- RevenueCNY 1.13B
- Net incomeCNY 257.26M
- Free cash flowCNY 120.49M
- Gross margin88.3%
Valuation Snapshot
latest market cap is CNY 17.91B; P/E is 18.3; dividend yield is 3.6%.
Peer valuation comparison
Latest P/E is 18.34x versus a Healthcare sector median of 21.75x (15.7% below).
Latest dividend yield is 3.6% versus a Healthcare sector median of 2.4% (50.0% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 17.91B | 18.3 | 3.6% | 0.7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.7 CNY, yield 3.6%.
About Chengdu Kanghong Pharmaceutical Group Co., Ltd
Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Chengdu Kanghong Pharmaceutical Group Co., Ltd's market cap?
Chengdu Kanghong Pharmaceutical Group Co., Ltd's market capitalization is CNY 17.91B.
What is Chengdu Kanghong Pharmaceutical Group Co., Ltd's P/E ratio?
Chengdu Kanghong Pharmaceutical Group Co., Ltd's price-to-earnings (P/E) ratio is 18.3.
Does Chengdu Kanghong Pharmaceutical Group Co., Ltd pay a dividend?
Chengdu Kanghong Pharmaceutical Group Co., Ltd has a dividend yield of 3.6%.
What does Chengdu Kanghong Pharmaceutical Group Co., Ltd do?
Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.